Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
GM1 structural requirements to mediate neuronal functions.
Fazzari M, Lunghi G, Di Biase E, Maggioni M, Carsana EV, Cioccarelli L, Vigani L, Loberto N, Aureli M, Mauri L, Ciampa MG, Valsecchi M, Takato K, Imamura A, Ishida H, Ben Mariem O, Saporiti S, Palazzolo L, Chiricozzi E, Eberini I, Sonnino S. Fazzari M, et al. Among authors: ciampa mg. Glycoconj J. 2023 Dec;40(6):655-668. doi: 10.1007/s10719-023-10141-8. Epub 2023 Dec 15. Glycoconj J. 2023. PMID: 38100017
GM1 Ganglioside: Past Studies and Future Potential.
Aureli M, Mauri L, Ciampa MG, Prinetti A, Toffano G, Secchieri C, Sonnino S. Aureli M, et al. Among authors: ciampa mg. Mol Neurobiol. 2016 Apr;53(3):1824-1842. doi: 10.1007/s12035-015-9136-z. Epub 2015 Mar 12. Mol Neurobiol. 2016. PMID: 25762012 Review.
On the use of cholera toxin.
Chiricozzi E, Mauri L, Ciampa MG, Prinetti A, Sonnino S. Chiricozzi E, et al. Among authors: ciampa mg. Glycoconj J. 2018 Apr;35(2):161-163. doi: 10.1007/s10719-018-9818-7. Epub 2018 Apr 7. Glycoconj J. 2018. PMID: 29627921 No abstract available.
Parkinson's disease recovery by GM1 oligosaccharide treatment in the B4galnt1+/- mouse model.
Chiricozzi E, Mauri L, Lunghi G, Di Biase E, Fazzari M, Maggioni M, Valsecchi M, Prioni S, Loberto N, Pomè DY, Ciampa MG, Fato P, Verlengia G, Cattaneo S, Assini R, Wu G, Alselehdar S, Ledeen RW, Sonnino S. Chiricozzi E, et al. Among authors: ciampa mg. Sci Rep. 2019 Dec 18;9(1):19330. doi: 10.1038/s41598-019-55885-2. Sci Rep. 2019. PMID: 31852959 Free PMC article.
GM1 Oligosaccharide Efficacy in Parkinson's Disease: Protection against MPTP.
Fazzari M, Lunghi G, Henriques A, Callizot N, Ciampa MG, Mauri L, Prioni S, Carsana EV, Loberto N, Aureli M, Mari L, Sonnino S, Chiricozzi E, Di Biase E. Fazzari M, et al. Among authors: ciampa mg. Biomedicines. 2023 Apr 28;11(5):1305. doi: 10.3390/biomedicines11051305. Biomedicines. 2023. PMID: 37238977 Free PMC article.
GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro.
Fazzari M, Di Biase E, Zaccagnini L, Henriques A, Callizot N, Ciampa MG, Mauri L, Carsana EV, Loberto N, Aureli M, Mari L, Civera M, Vasile F, Sonnino S, Bartels T, Chiricozzi E, Lunghi G. Fazzari M, et al. Among authors: ciampa mg. Biochim Biophys Acta Mol Cell Biol Lipids. 2023 Sep;1868(9):159350. doi: 10.1016/j.bbalip.2023.159350. Epub 2023 Jun 16. Biochim Biophys Acta Mol Cell Biol Lipids. 2023. PMID: 37330108 Free article.
GM1 ganglioside exerts protective effects against glutamate-excitotoxicity via its oligosaccharide in wild-type and amyotrophic lateral sclerosis motor neurons.
Lunghi G, Di Biase E, Carsana EV, Henriques A, Callizot N, Mauri L, Ciampa MG, Mari L, Loberto N, Aureli M, Sonnino S, Spedding M, Chiricozzi E, Fazzari M. Lunghi G, et al. Among authors: ciampa mg. FEBS Open Bio. 2023 Dec;13(12):2324-2341. doi: 10.1002/2211-5463.13727. Epub 2023 Nov 15. FEBS Open Bio. 2023. PMID: 37885330 Free PMC article.
27 results